Skip to main content
TipRanks
Go Ultimate75% OFF

Bruker (BRKR) Capital Expenditure by Segment

493 Followers

Capital Expenditure by Segment

Bruker reported capital expenditure by segment of $10.90M in Q3 2026, down 46.3% from Q2 2026 and down 41.4% year over year. The highest value was $36.80M in Q4 2024.

Tracks where Bruker is investing in plant, equipment, and infrastructure across its segments, indicating commitments to capacity expansion, product development, or maintenance. Large or sustained capex in a segment can point to future growth opportunities but also raises cash needs and execution risk.

-$10.00M$0.00$10.00M$20.00M$30.00MMar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

CapEx is clearly lumpy and project‑driven: large 2024–25 investments in BioSpin and CALID have mostly run their course (BioSpin spending falling to near‑zero by mid‑2026), which should free cash and support the margin and leverage improvements management is pushing. Meanwhile NANO and CALID still show episodic big spend consistent with the company’s semiconductor/deep‑tech push — capex likely precedes revenue because of long lead times — and declining BEST spend suggests lower priority or consolidation in that business.

BRKR Capital Expenditure by Segment

PeriodCorporate & OtherBSI BioSpinBSI CALIDBSI NANOBESTTotal
Q3 2026Sep 30, 2026$2.10M$0.00$0.00$6.70M$2.10M$10.90M
Q2 2026Jun 30, 2026$3.50M$0.00$6.50M$7.50M$2.80M$20.30M
Q1 2026Mar 31, 2026$2.30M$2.40M$6.70M$4.90M$1.60M$17.90M
Q4 2025Dec 31, 2025$2.90M$1.10M$4.30M$15.30M$4.50M$28.10M
Q3 2025Sep 30, 2025$1.50M$4.80M$7.10M$3.10M$2.10M$18.60M
Q2 2025Jun 30, 2025$6.90M$2.30M$5.50M$13.20M$2.40M$30.30M
Q1 2025Mar 31, 2025$4.70M$3.20M$8.40M$4.90M$4.80M$26.00M
Q4 2024Dec 31, 2024$3.90M$6.00M$15.90M$4.80M$6.20M$36.80M
Q3 2024Sep 30, 2024$4.20M$13.40M$6.50M$4.30M$4.20M$32.60M
Q2 2024Jun 30, 2024$4.00M$3.80M$6.40M$4.00M$6.30M$24.50M
Q1 2024Mar 31, 2024$2.70M-$400.00K$5.30M$6.20M$7.60M$21.40M

Related KPIs